Patient data
.  | Patient no. 1 .  | Patient no. 2 .  | Patient no. 3 .  | Patient no. 4 .  | Patient no. 5 .  | Patient no. 6 .  | 
|---|---|---|---|---|---|---|
| Age, y | 50 | 49 | 24 | 26 | 47 | 17 | 
| Sex | Male | Female | Male | Male | Male | Male | 
| Diagnosis | FL | MM | CML | CML | MM | AML | 
|  When cGVHD developed  |  After PBSCT  |  After PBSCT  |  After BMT  |  After DLI  |  After 2nd DLI  |  After DLI  | 
.  | Patient no. 1 .  | Patient no. 2 .  | Patient no. 3 .  | Patient no. 4 .  | Patient no. 5 .  | Patient no. 6 .  | 
|---|---|---|---|---|---|---|
| Age, y | 50 | 49 | 24 | 26 | 47 | 17 | 
| Sex | Male | Female | Male | Male | Male | Male | 
| Diagnosis | FL | MM | CML | CML | MM | AML | 
|  When cGVHD developed  |  After PBSCT  |  After PBSCT  |  After BMT  |  After DLI  |  After 2nd DLI  |  After DLI  | 
FL indicates follicular lymphoma; MM, multiple myeloma; CML, chronic myeloid leukemia; AML, acute myeloid leukemia; PBSCT, allogeneic peripheral blood SCT; BMT, bone marrow transplantation; and DLI, donor lymphocyte infusion.